University of California San Francisco
Helen Diller Family Comprehensive Cancer Center

Conducting Research on Subjects Diagnosed with, or at Risk for, Cancer

Conducting Research on Subjects Diagnosed with, or at Risk for, Cancer

Because UCSF is home to the Helen Diller Family Comprehensive Cancer Center (HDFCCC), designated and supported by the National Cancer Institute (NCI), all protocols designed to conduct research on subjects diagnosed with, or at risk for, cancer are subject to additional review and monitoring processes not required of non-cancer protocols.  Therefore, in addition to requiring review by the UCSF IRB, your cancer-related protocols are subject to:

Such protocols may also be eligible to receive centralized support from the Investigational Trials Resource.

Other Clinical Research Resources

*  Initial approval must precede initial UCSF IRB approval.

** Can include studies written by an investigator at another institution.

This unit is supported by a National Cancer Institute Cancer Center Support Grant (P30CA082103). Any publications related to work done by this core should reference grant number P30CA082103 and must include a PMCID as required by the NIH. View instructions on how to acknowledge funding sources and how to obtain a PMCID.

For general inquiries about Cancer Center Shared Resources, please email Charissa Suantawee. For technical inquiries, please email Benjamin Braun, MD, PhD.

For more information on the CCSG, please email Erin Bank, PhD.